Docencia
Immunological and infectious risk factors for lung cancer in US veterans with HIV: a longitudinal cohort study (01-03-2017)
Dr. José Ramón Blanco. Investigador de la Unidad de VIH y Alteraciones Metabólicas Asociadas. Centro de investigación Biomédica de La Rioja
Benefits and Risks of Antiretroviral Therapy for Perinatal HIV Prevention (15-02-2017)
Dra. Marisa Montes. Unidad de enfermedades infecciosas. Hospital Universitario de la Paz. Madrid
Switching to Raltegravir From a Virologically Effective Boosted Protease Inhibitor Regimen: A Comparative Effectiveness Analysis From the French Hospital Database on HIV (FHDH-ANRS CO4) (01-02-2017)
Dr. Javier de la Torre Lima. Servicio de Medicina Interna. Hospital Costa del Sol. Marbella
Impact of the Centers for Disease Control’s HIV Preexposure Prophylaxis Guidelines for Men Who Have Sex With Men in the United States (16-01-2017)
Dra. Concha Amador. Médico de Enfermedades Infecciosas. Hospital Villajoyosa de Alicante
High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial (02-01-2017)
Dr. José A. Pérez Molina. Servicio de Enfermedades Infecciosas. Hospital Universitario Ramón y Cajal
Chronic Hepatitis B and C Virus Infection and Risk for Non-Hodgkin Lymphoma in HIV-Infected Patients A Cohort Study (15-12-2016)
Dr. Adrian Currán. Atencion sanitaria y hospitalaria. Hospital Universitari de la Vall d´Hebron.
Suboptimal cART Adherence is Associated with Higher Levels of Inflammation Despite HIV Suppression (01-12-2016)
Dr. José Ramón Blanco. Investigador de la Unidad de VIH y Alteraciones Metabólicas Asociadas. Centro de investigación Biomédica de La Rioja
Is protease inhibitors based antiretroviral therapy during pregnancy associated with an increased risk of preterm birth? Systematic review and a meta-analysis (17-11-2016)
Dra. Marisa Montes. Unidad de enfermedades infecciosas. Hospital Universitario de la Paz. Madrid
Cause-Specific Mortality in HIV-Positive Patients Who Survived Ten Years After Starting Antiretroviral Therapy (28-10-2016)
Dr. Javier de la Torre Lima. Servicio de Medicina Interna. Hospital Costa del Sol. Marbella
Antiretroviral Therapy for Prevention of HIV-1 Transmission (17-10-2016)
Dra. Concha Amador Prous. Médico de Enfermedades Infecciosas. Hospital Villajoyosa de Alicante
Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy. ESTUDIO PARTNER (30-09-2016)
Dr. José A. Pérez Molina. Servicio de Enfermedades Infecciosas. Hospital Universitario Ramón y Cajal. Madrid
HLA-B18 as a risk factor of short-term progression to severe liver fibrosis in HIV/HCV co-infected patients with absent or minimal fibrosis: Implications for timing of therapy (15-06-2016)
Dr. Antonio Rivero. Jefe de sección de Enfermedades Infecciosas. Hospital Universitario Reina Sofía. Córdoba
Non-nucleoside reverse transcriptase inhibitor- versus ritonavir-boosted proteaseinhibitor-based regimens for initial treatment of HIV infection: A systematic review andmeta-analysis of randomised trials (01-06-2016)
Dr. Federico Pulido. Unidad de Infección VIH. Hospital 12 de Octubre. Madrid
Narrowing the gap in life expectancy between HIV-infected and HIV-uninfected individuals with access to care (17-05-2016)
Dra. María Jesús Téllez. Servicio de Medicina Interna/ Unidad VIH. Hospital Clínico San Carlos. Madrid
Adjunctive Dexamethasone in HIV-Associated Cryptococcal Meningitis (03-05-2016)
Dr. Felix Gutiérrez. Departamento de Medicina Clínica. Hospital General Universitario.Elche
A Phase III Trial of the Dapivirine Vaginal Ring for HIV-1 Preven:on in Women (15-04-2016)
Dr. Josep Maria Llibre. Departamento de Medicina interna y Unidad de VIH. Hospital Germans Trias i Pujol. Badalona
CD8 T-Cell Expansion and Inflammation Linked to CMV Coinfection in ART-treated HIV Infection (01-04-2016)
Dr. Juan Berenguer. Consultor de la Unidad de Enf. Infecciosas y VIH. Hospital Universitario Gregorio Marañón. Madrid
Ledipasvir Plus Sofosbuvir in Treatment- Naïve or-experienced Patients With Hepatitis C Genotype 5 Infection: An Open-Label, Phase 2 study Abergel A, et al. Lancet Infectious Diseases, 2016 (15-03-2016)
Dr. Antonio Rivero. Jefe de sección de Enfermedades Infecciosas. Hospital Universitario Reina Sofía. Córdoba
Switching from TDF to TAF in antiretroviral regimens for virologically suppressed adults with HIV-1 infection: A randomised, active-controlled, multicentre, open-label, phase 3, non-inferiority study. ENSAYO GS-US-292-0109 (01-03-2016)
Dr. Federico Pulido. Unidad de Infección VIH. Hospital 12 de Octubre. Madrid
